One direct-acting anticoagulant stands out as the least likely to cause dangerous bleeding in elderly patients with atrial fibrillation, according to a new study. But other new research questions the ...
This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...
In patients with atrial fibrillation (AF) with a recent episode of intracranial hemorrhage (ICH), the use of oral anticoagulants significantly reduced net adverse clinical events — primarily driven by ...
THE nature of the valvular lesions in subacute bacterial endocarditis makes the use of anticoagulants appear a logical procedure in the prevention of fibrin formation. Such agents should thereby keep ...
Varese, Italy - A meta-analysis of 12 randomized trials of novel anticoagulants in atrial fibrillation (AF) patients shows that replacing warfarin with the new drugs could save one life for every 244 ...
Anticoagulants are medications that help stop your blood from thickening or “clotting.” Your body does need to be able to clot to help seal wounds inside and outside your body. But unnecessary clots ...
Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) The systematic review included 35 publications on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results